Pharmacists Should Assume a Larger Role in Overcoming the Racial/Ethnic Barriers to Breast Cancer Screening

por Kachroo, Sumesh
Publicado 2006

Chemotherapy treatments, costs of care, and survival for patients diagnosed with small cell lung cancer: A SEER‐Medicare study

por Shao, Changxia, He, Jinghua, Kachroo, Sumesh, Jin, Fan
Publicado 2019

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line

por Svedbom, Axel, Dalén, Johan, Black, Christopher M, Kachroo, Sumesh
Publicado 2017

Dose Escalation and Healthcare Resource Use among Ulcerative Colitis Patients Treated with Adalimumab in English Hospitals: An Analysis of Real-World Data

por Black, Christopher M., Yu, Eric, McCann, Eilish, Kachroo, Sumesh
Publicado 2016

Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthrit...

por Svedbom, Axel, Storck, Chiara, Kachroo, Sumesh, Govoni, Marinella, Khalifa, Ahmed
Publicado 2017

Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany

por Waller, John, Sullivan, Emma, Piercy, James, Black, Christopher M, Kachroo, Sumesh
Publicado 2017

Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across Germany

por Sullivan, Emma, Piercy, James, Waller, John, Black, Christopher M., Kachroo, Sumesh
Publicado 2017

Healthcare-Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis: a Retrospective Study

por Dalén, Johan, Luttropp, Karin, Svedbom, Axel, Black, Christopher M., Kachroo, Sumesh
Publicado 2020

Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective

por Borse, Rebekah H., Brown, Chloe, Muszbek, Noemi, Chaudhary, Mohammad Ashraf, Kachroo, Sumesh
Publicado 2017

Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the United States

por Zhdanava, Maryia, Zhao, Ruizhi, Manceur, Ameur M, Kachroo, Sumesh, Lefebvre, Patrick, Pilon, Dominic
Publicado 2023

Remote Monitoring of Patient-Reported Outcomes in Ulcerative Colitis: A Prospective Real-World Pilot Study

por Sebastian, Shaji, Roberts, Jenna, Waller, John, Judge, Davneet, Brown, Chloe, Davies, Ruth, Kachroo, Sumesh
Publicado 2019

Evaluation of Treatment Patterns and Maintenance Dose Titration Among Patients With Crohn’s Disease Initiating Biologics With 3 Years of Follow-Up

por Zhao, Ruizhi, Ding, Zhijie, Gupta, Parul, Gozalo, Laurence, Bruette, Robert, Johnson, Victor M., Maughn, Keshia, Liu, Yihang, Kachroo, Sumesh
Publicado 2023

Provider beliefs about diabetes treatment have little impact on glycemic control of their patients with diabetes

por LeBlanc, Erin S, Rosales, A Gabriela, Kachroo, Sumesh, Mukherjee, Jayanti, Funk, Kristine L, Schneider, Jennifer L, Nichols, Gregory A
Publicado 2015

Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review

por Luttropp, Karin, Dozier, Mary, Justo, Nahila, Cornillie, Freddy, Kachroo, Sumesh, Govoni, Marinella, Salomonsson, Stina, Black, Christopher M, Khalifa, Ahmed
Publicado 2019

Long-term outcomes of colectomy surgery among patients with ulcerative colitis

por Brown, Carl, Gibson, Peter R., Hart, Ailsa, Kaplan, Gilaad G., Kachroo, Sumesh, Ding, Qian, Hautamaki, Emily, Fan, Tao, Black, Christopher M., Hu, Xiaohan, Beusterien, Kathleen
Publicado 2015